{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:55:16Z","timestamp":1790949316390,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T00:00:00Z","timestamp":1534896000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11033-018-4307-4","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T02:44:03Z","timestamp":1534905843000},"page":"1413-1419","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Whole exome sequencing of breast cancer (TNBC) cases from India: association of MSH6 and BRIP1 variants with TNBC risk and oxidative DNA damage"],"prefix":"10.1007","volume":"45","author":[{"given":"M.","family":"Aravind Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8952-9581","authenticated-orcid":false,"given":"Shaik Mohammad","family":"Naushad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narasimhulu","family":"Narasimgu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nagaraju Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srilatha","family":"Kadali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday","family":"Shanker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lakshmi Narasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,22]]},"reference":[{"key":"4307_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10549-016-4062-y","volume":"161","author":"FO Ademuyiwa","year":"2016","unstructured":"Ademuyiwa FO, Tao Y, Luo J et al (2016) Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians. Breast Cancer Res Treat 161:491\u2013499. \n                    https:\/\/doi.org\/10.1007\/s10549-016-4062-y","journal-title":"Breast Cancer Res Treat"},{"key":"4307_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126762","author":"F Vaca-Paniagua","year":"2015","unstructured":"Vaca-Paniagua F, Alvarez-Gomez RM, Maldonado-Mart\u00ednez HA et al (2015) Revealing the molecular portrait of triple negative breast tumors in an understudied population through omics analysis of formalin-fixed and paraffin-embedded tissues. PLoS ONE. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0126762","journal-title":"PLoS ONE"},{"key":"4307_CR3","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2481","author":"M Kriegsmann","year":"2014","unstructured":"Kriegsmann M, Endris V, Wolf T et al (2014) Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences. Oncotarget. \n                    https:\/\/doi.org\/10.18632\/oncotarget.2481","journal-title":"Oncotarget"},{"key":"4307_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nature11154","volume":"486","author":"S Banerji","year":"2012","unstructured":"Banerji S, Cibulskis K, Rangel-Escareno C et al (2012) Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 486:405\u2013409. \n                    https:\/\/doi.org\/10.1038\/nature11154","journal-title":"Nature"},{"key":"4307_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-017-3187-6","volume":"442","author":"MA Kumar","year":"2017","unstructured":"Kumar MA, Singh V, Naushad SM et al (2017) Microarray-based SNP genotyping to identify genetic risk factors of triple-negative breast cancer (TNBC) in South Indian population. Mol Cell Biochem 442:1\u201310. \n                    https:\/\/doi.org\/10.1007\/s11010-017-3187-6","journal-title":"Mol Cell Biochem"},{"key":"4307_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/14737159.2018.1407243","volume":"18","author":"C Mayo-De-Las-Casas","year":"2017","unstructured":"Mayo-De-Las-Casas C, Ib\u00e1\u00f1ez MG, Jordana-Ariza N et al (2017) An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer. Expert Rev Mol Diagn 18:35\u201345. \n                    https:\/\/doi.org\/10.1080\/14737159.2018.1407243","journal-title":"Expert Rev Mol Diagn"},{"key":"4307_CR7","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1093\/bioinformatics\/btp528","volume":"25","author":"B Li","year":"2009","unstructured":"Li B, Krishnan VG, Mort ME et al (2009) Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics 25:2744\u20132750. \n                    https:\/\/doi.org\/10.1093\/bioinformatics\/btp528","journal-title":"Bioinformatics"},{"key":"4307_CR8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA Depristo","year":"2011","unstructured":"Depristo MA, Banks E, Poplin R et al (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43:491\u2013498. \n                    https:\/\/doi.org\/10.1038\/ng.806","journal-title":"Nat Genet"},{"key":"4307_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.7707\/hmj.v5i3.174","volume":"5","author":"B Chen","year":"2012","unstructured":"Chen B, Thong M, Yunus Z (2012) Biochemical profiling of inborn errors of purine and pyrimidine metabolism by high-performance liquid chromatography: a strategy to improve childhood mortality and morbidity in Malaysian children. Hamdan Med J 5:363. \n                    https:\/\/doi.org\/10.7707\/hmj.v5i3.174","journal-title":"Hamdan Med J"},{"key":"4307_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s0009-8981(03)00291-2","volume":"335","author":"C Vidotto","year":"2003","unstructured":"Vidotto C, Fousert D, Akkermann M et al (2003) Purine and pyrimidine metabolites in children\u2019s urine. Clin Chim Acta 335:27\u201332. \n                    https:\/\/doi.org\/10.1016\/s0009-8981(03)00291-2","journal-title":"Clin Chim Acta"},{"key":"4307_CR11","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1097\/pas.0b013e3182627787","volume":"36","author":"YH Wen","year":"2012","unstructured":"Wen YH, Brogi E, Zeng Z et al (2012) DNA mismatch repair deficiency in breast carcinoma. Am J Surg Pathol 36:1700\u20131708. \n                    https:\/\/doi.org\/10.1097\/pas.0b013e3182627787","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"4307_CR12","first-page":"2113","volume":"5","author":"M Ollier","year":"2015","unstructured":"Ollier M, Radosevic-Robin N, Kwiatkowski F, Ponelle F, Viala S, Privat M, Uhrhammer N, Bernard-Gallon D, Penault-Llorca F, Bignon YJ, Bidet Y (2015) DNA repair genes implicated in triple negative familial non-BRCA1\/2 breast cancer predisposition. Am J Cancer Res 5(7):2113\u20132126","journal-title":"Am J Cancer Res"},{"key":"4307_CR13","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1080\/01635581.2014.932397","volume":"66","author":"E Lee","year":"2014","unstructured":"Lee E, Levine EA, Franco VI et al (2014) Combined genetic and nutritional risk models of triple negative breast cancer. Nutr Cancer 66:955\u2013963. \n                    https:\/\/doi.org\/10.1080\/01635581.2014.932397","journal-title":"Nutr Cancer"},{"key":"4307_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1200\/jco.2014.57.1414","volume":"33","author":"FJ Couch","year":"2015","unstructured":"Couch FJ, Hart SN, Sharma P et al (2015) Inherited mutations in 17 Breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol 33:304\u2013311. \n                    https:\/\/doi.org\/10.1200\/jco.2014.57.1414","journal-title":"J Clin Oncol"},{"key":"4307_CR15","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7027","author":"P-H Lin","year":"2016","unstructured":"Lin P-H, Kuo W-H, Huang A-C et al (2016) Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer. Oncotarget. \n                    https:\/\/doi.org\/10.18632\/oncotarget.7027","journal-title":"Oncotarget"},{"key":"4307_CR16","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/cncr.30498","volume":"123","author":"SS Buys","year":"2017","unstructured":"Buys SS, Sandbach JF, Gammon A et al (2017) A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer 123:1721\u20131730. \n                    https:\/\/doi.org\/10.1002\/cncr.30498","journal-title":"Cancer"},{"key":"4307_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2741\/e767","volume":"8","author":"A Ouhtit","year":"2016","unstructured":"Ouhtit A, Gupta I, Shaikh Z (2016) BRIP1, a potential candidate gene in development of non-BRCA1\/2 breast cancer. Front Biosci 8:289\u2013298","journal-title":"Front Biosci"},{"key":"4307_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006248","author":"A Rump","year":"2016","unstructured":"Rump A, Benet-Pages A, Schubert S et al (2016) Identification and functional testing of ERCC2 mutations in a multi-national cohort of patients with familial breast- and ovarian cancer. PLoS Genet. \n                    https:\/\/doi.org\/10.1371\/journal.pgen.1006248","journal-title":"PLoS Genet"},{"key":"4307_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-262","author":"P Karihtala","year":"2011","unstructured":"Karihtala P, Kauppila S, Soini Y, Arja-Jukkola-Vuorinen (2011) Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas. BMC Cancer. \n                    https:\/\/doi.org\/10.1186\/1471-2407-11-262","journal-title":"BMC Cancer"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-018-4307-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-018-4307-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-018-4307-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T19:26:58Z","timestamp":1566415618000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-018-4307-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,22]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["4307"],"URL":"https:\/\/doi.org\/10.1007\/s11033-018-4307-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,22]]},"assertion":[{"value":"2 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors has a financial or other relationship with other people or organizations that may inappropriately influence this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by Institutional Ethical committee of This study was approved by The Institutional ethical committee of Sandor Proteomics Pvt Ltd, Hyderabad, India. (EC\/SRP\/008\/2012, Dated 26.6.12.) This study complied with the ethical principles outlined in the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all the study participants (Cases as well as controls) during their enrollment for the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}